These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21368795)

  • 1. Targeted gene editing enters clinic.
    Ledford H
    Nature; 2011 Mar; 471(7336):16. PubMed ID: 21368795
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive results with autologous transplant of ZFN-modified CD4 T-cells: a step toward a practical, functional cure for HIV.
    AIDS Patient Care STDS; 2011 Nov; 25(11):693. PubMed ID: 22023317
    [No Abstract]   [Full Text] [Related]  

  • 3. Autologous CCR5-modified CD4 T-cells effective in HAART nonresponders.
    AIDS Patient Care STDS; 2011 Nov; 25(11):693. PubMed ID: 22132424
    [No Abstract]   [Full Text] [Related]  

  • 4. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.
    Didigu CA; Wilen CB; Wang J; Duong J; Secreto AJ; Danet-Desnoyers GA; Riley JL; Gregory PD; June CH; Holmes MC; Doms RW
    Blood; 2014 Jan; 123(1):61-9. PubMed ID: 24162716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling HIV infection: HIV co-receptor gets the finger.
    Kelleher AD; Purcell DF
    Immunol Cell Biol; 2008; 86(8):641-2. PubMed ID: 18779839
    [No Abstract]   [Full Text] [Related]  

  • 7. Dual zinc-finger nucleases block HIV infection.
    Durand CM; Siliciano RF
    Blood; 2014 Jan; 123(1):2-3. PubMed ID: 24385492
    [No Abstract]   [Full Text] [Related]  

  • 8. How doctors are re-engineering the immune system to fight HIV infection.
    Roehr B
    BMJ; 2011 Mar; 342():d1373. PubMed ID: 21363862
    [No Abstract]   [Full Text] [Related]  

  • 9. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
    J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
    J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
    Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
    AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV swiftly guts the immune system.
    Veazey RS; Lackner AA
    Nat Med; 2005 May; 11(5):469-70. PubMed ID: 15875046
    [No Abstract]   [Full Text] [Related]  

  • 13. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
    J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.
    Butticaz C; Ciuffi A; Muñoz M; Thomas J; Bridge A; Pebernard S; Iggo R; Meylan P; Telenti A
    Antivir Ther; 2003 Oct; 8(5):373-7. PubMed ID: 14640383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human immunodeficiency virus (HIV) co-receptors expression in mononuclear leucocytes (ML) of HIV+ patients].
    Belmonte L; de Elizalde de Bracco MM; Ruibal-Ares B
    Medicina (B Aires); 2001; 61(5 Pt 2):670-2. PubMed ID: 12058586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.
    Paxton WA; Liu R; Kang S; Wu L; Gingeras TR; Landau NR; Mackay CR; Koup RA
    Virology; 1998 Apr; 244(1):66-73. PubMed ID: 9581779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5.
    Maier DA; Brennan AL; Jiang S; Binder-Scholl GK; Lee G; Plesa G; Zheng Z; Cotte J; Carpenito C; Wood T; Spratt SK; Ando D; Gregory P; Holmes MC; Perez EE; Riley JL; Carroll RG; June CH; Levine BL
    Hum Gene Ther; 2013 Mar; 24(3):245-58. PubMed ID: 23360514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infection.
    Soares R; Foxall R; Albuquerque A; Cortesão C; Garcia M; Victorino RM; Sousa AE
    J Virol; 2006 Dec; 80(24):12425-9. PubMed ID: 17035326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5.
    Lin YL; Mettling C; Portalès P; Rouzier R; Clot J; Reynes J; Corbeau P
    AIDS; 2008 Jan; 22(3):430-2. PubMed ID: 18195571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.